Cabaletta Bio (CABA) Stock Forecast & Price Target
CABA Analyst Ratings
Strong Buy
7Buy1Hold0Sell
Based on 8 analysts giving stock ratings to Cabaletta Bio in the past 3 months
CABA Stock 12 Month Forecast
Average Price Target
MXN 272.13▲(943.46% Upside)Based on 8 Wall Street analysts offering 12 month price targets for Cabaletta Bio in the last 3 months. The average price target is MXN 272.13 with a high forecast of MXN 556.64 and a low forecast of MXN 55.66. The average price target represents a 943.46% change from the last price of MXN 26.08.
Past 12 Months12 Month ForecastDec2025Sep2026
HighMXN 556.64
AverageMXN 272.13
LowMXN 55.66
Highest Price TargetHighestMXN 556.64Average Price TargetMXN 272.13Lowest Price TargetLowestMXN 55.66
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Douglas Tsao | H.C. Wainwright | MXN 296.87 | buy | 1038.32%Upside | Reiterated | 09/21/26 | ||
| Phil Nadeau | TD Cowen | ― | buy | ― | Reiterated | 09/02/26 | ||
 Unknown AnalystNot Ranked | Wells Fargo | MXN 55.66 | hold | 113.43%Upside | Assigned | 09/01/26 | ||
| Samantha Semenkow | Citi | MXN 185.55 | buy | 611.45%Upside | Reiterated | 09/01/26 | ||
| Michael Ulz | Morgan Stanley | MXN 241.21 | buy | 824.88%Upside | Assigned | 08/17/26 | ||
| Joshua Schimmer | Cantor Fitzgerald | MXN 556.64 | buy | 2034.35%Upside | Reiterated | 08/14/26 | ||
| Sami Corwin | William Blair | ― | buy | ― | Reiterated | 08/13/26 | ||
| Yatin Suneja | Guggenheim | MXN 296.87 | buy | 1038.32%Upside | Reiterated | 08/13/26 | ||
| Roger Song | Jefferies | MXN 259.76 | buy | 896.03%Upside | Reiterated | 03/23/26 | ||
| Gavin Clark-Gartner | Evercore ISI | MXN 74.22 | hold | 184.58%Upside | Reiterated | 12/17/25 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Douglas Tsao | 09/21/26 | MXN 296.87 | buy | 1038.32%Upside | Reiterated | H.C. Wainwright | ||
| Phil Nadeau | 09/02/26 | ― | buy | ― | Reiterated | TD Cowen | ||
| Unknown AnalystNot Ranked | 09/01/26 | MXN 55.66 | hold | 113.43%Upside | Assigned | Wells Fargo | ||
| Samantha Semenkow | 09/01/26 | MXN 185.55 | buy | 611.45%Upside | Reiterated | Citi | ||
| Michael Ulz | 08/17/26 | MXN 241.21 | buy | 824.88%Upside | Assigned | Morgan Stanley | ||
| Joshua Schimmer | 08/14/26 | MXN 556.64 | buy | 2034.35%Upside | Reiterated | Cantor Fitzgerald | ||
| Sami Corwin | 08/13/26 | ― | buy | ― | Reiterated | William Blair | ||
| Yatin Suneja | 08/13/26 | MXN 296.87 | buy | 1038.32%Upside | Reiterated | Guggenheim | ||
| Roger Song | 03/23/26 | MXN 259.76 | buy | 896.03%Upside | Reiterated | Jefferies | ||
| Gavin Clark-Gartner | 12/17/25 | MXN 74.22 | hold | 184.58%Upside | Reiterated | Evercore ISI |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Cabaletta Bio
3 Months
Success Rate10/22 ratings generated profit
45%
Average Return
-3.88%
Copying Douglas Tsao's trades and holding each position for 3 Months would result in 45.45% of your transactions generating a profit, with an average return of -3.88% per trade.
1 Year
Success Rate5/18 ratings generated profit
28%
Average Return
-17.81%
Copying Michael Ulz's trades and holding each position for 1 Year would result in 27.78% of your transactions generating a profit, with an average return of -17.81% per trade.
2 Years
Success Rate2/18 ratings generated profit
11%
Average Return
-47.60%
Copying Michael Ulz's trades and holding each position for 2 Years would result in 11.11% of your transactions generating a profit, with an average return of -47.60% per trade.
CABA Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 12 | 9 | 6 | 6 | 6 |
| Buy | 7 | 5 | 4 | 2 | 2 |
| Hold | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 20 | 15 | 11 | 10 | 10 |
In the current month, CABA has received 8 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. CABA average Analyst price target in the past 3 months is 272.13.
CABA Financial Forecast
HighMXN -4.51
ConsensusMXN -5.96
LowMXN -6.58
CABA Earnings Forecast
Next quarter’s earnings estimate for CABA is -MXN 5.96 with a range of -MXN 6.58 to -MXN 4.51. The previous quarter’s EPS was -MXN 6.39. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighMXN 0.00
ConsensusMXN 0.00
LowMXN 0.00
CABA Sales Forecast
Next quarter’s sales forecast for CABA is MXN 0 with a range of MXN 0 to MXN 0. The previous quarter’s sales results were MXN 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
CABA Stock Forecast FAQ
What is MX:CABA’s average 12-month price target, according to analysts?
Based on analyst ratings, Cabaletta Bio’s 12-month average price target is Mex$272.13.
What is MX:CABA’s upside potential, based on the analysts’ average price target?
Cabaletta Bio has 943.46% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Cabaletta Bio a Buy, Sell or Hold?
Cabaletta Bio has a consensus rating of Strong Buy, which is based on 7 buy ratings, 1 hold ratings and 0 sell ratings.
What is Cabaletta Bio’s share price target?
The average share price target for Cabaletta Bio is Mex$272.13. This is based on 8 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$556.64, and the lowest forecast is Mex$55.66. The average share price target represents a 943.46% increase from the current price of Mex$26.08.
What do analysts say about Cabaletta Bio?
Cabaletta Bio’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Street analysts.
How can I buy shares of Cabaletta Bio?
To buy shares of MX:CABA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.